Month: May 2023

—Upon issuance, patent will be the fourth Japanese patent to issue for the ThermoStem®program targeting obesity and metabolic disorders, including type 2 diabetes–  MELVILLE, N.Y., May 15, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that the Japanese Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company’s metabolic ThermoStem® program. The notice of allowance was issued on May 8, 2023. Upon issuance, this will be the fourth patent granted in Japan for the ThermoStem® program. Claims granted under the new Japanese patent will cover implantable three-dimensional scaffolds and brown adipocytes that have been derived from...

WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will attend and present at the ATS 2023 Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society, on May 19-20, 2023 in Washington, DC. Dr. Neil will present on AVTX-002 in non-eosinophilic asthma during Showcase One: Asthma, COPD, and Airway Inflammation Innovators at 8:30am ET on Saturday, May 20, 2023. About ATS 2023 Respiratory Innovation Summit Hosted by the American Thoracic Society, the 2023 Respiratory Innovation Summit unites innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. This meeting...

OTL-200 Biologics License Application (BLA) submission completion anticipated in mid-2023 Libmeldy revenue and commercial patients treated expected to grow year-over-year in 2023 New clinical data in MPS-I and MPS-IIIA and pre-clinical data in genetic subsets of frontotemporal dementia and Crohn’s to be presented this week at ASGCT Closed initial $34M of potential $188M in proceeds as part of strategic financing and ended Q1 2023 with $146M of cash and investments and runway into 2025 BOSTON and LONDON, May 15, 2023 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced various business accomplishments along with its financial results for the quarter ended March 31, 2023. “Following multiple productive interactions this year with the FDA on our clinical and CMC packages, I am delighted...

BOCA RATON, Fla., May 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that James Sapirstein, Chief Executive Officer of First Wave BioPharma, will present at the 2023 BIO International Conference on Tuesday, June 6 11:45 AM in Room 104A. The conference is taking place June 5-8 in the Boston Convention & Exhibition Center in Boston, Massachusetts. Details of the event are as follows:Event: 2023 BIO International ConferenceDate: Tuesday, June 6, 2023Time: 11:45 a.m. ETLocation: Room 104ARegistration: https://www.bio.org/events/bio-international-conventionMr. Sapirstein will provide an...

Figure 1 Mill building mechanical equipment installationFigure 2 Mill building top floor mechanical equipment installationFigure 3 Tailings thickener constructionFigure 4 Temporary WTP for tailings facility Spring water dischargeFigure 5 New WTP lime silos installedFigure 6 New WTP clarifier foundation pedestals installedFigure 7 New WTP MBBR tanks installedFigure 8 Electrical substation foundation constructionVANCOUVER, British Columbia, May 15, 2023 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is pleased to announce the Company’s unaudited financial results for the three months ended March 31, 2023 (“Q1 2023”), and also to provide a construction update on the Company’s Premier Gold Project (“PGP” or the “project”), located on Nisga’a Nation Treaty Lands in...

— Industry veteran brings more than 20 years of experience; will assume role effective July 1st — — During transition period Mr. Sapir will serve as special advisor to the interim CEO and president — CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the appointment of Alex C. Sapir as chief executive officer and president, effective July 1st, 2023. Upon assuming his new role, Mr. Sapir will also join Fulcrum’s board of directors. Interim CEO and president, Robert Gould Ph.D., will continue to serve as a member of the board of directors following the transition. “We are delighted to welcome Alex as our new CEO,” said Dr. Gould. “Alex brings a wealth...

OLINVYK receives regulatory approval in China, triggering $3 million milestone payment from Company’s China partner Jiangsu Nhwa Pharmaceutical Company expects to receive additional $15 million non-dilutive tranche from R-Bridge upon first commercial sale of OLINVYK in China TRV045 topline data expected in 3Q 2023 for two proof-of-concept studies supporting continued development for potential use in epilepsy and chronic pain Previously announced initial topline OLINVYK data demonstrated a statistically significant 1.6-day (~27%) reduction in average overall hospital length of stay compared to matched patients treated with other IV opioids, based on initial EMR analysis of patients at Wake Forest Baptist Health Company continues to expect new OLINVYK respiratory data and additional health utilization and cost analyses from ~200 patient...

LONDON, May 15, 2023 (GLOBE NEWSWIRE) — For the second consecutive year, leading global data analytics and technology provider Verisk (Nasdaq: VRSK) has been recognised as one of the UK’s Best Workplaces™ by Great Place to Work®, the global authority on workplace culture. Based on employee feedback, the recognition honours Verisk for creating an environment of trust, pride and camaraderie. To determine the 2023 UK’s Best Workplaces™ list, Great Place to Work® performed rigorous evaluations of hundreds of employee survey responses alongside Culture Audit™ submissions from leaders at each company. They then used the data to benchmark the effectiveness of companies’ employee value propositions against the culture their employees actually experience. Businesses that achieve the highest scores after...

Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome; topline results expected first-half 2024 $44.4 million in cash and cash equivalents at March 31, 2023; Cash runway to mid-year 2024 Proposal for a reverse stock split is on the agenda for June 13, 2023 annual meeting of stockholders to satisfy the minimum bid price requirement for continued listing on the Nasdaq Capital Market DEVON, Pa., May 15, 2023 (GLOBE NEWSWIRE) —  Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today reported financial results for the first quarter ended March 31, 2023, and provided an overview of recent operational highlights and a pipeline update. “The first...

Net Revenues for the First Quarter 2023 amounted to $851.2 Million, an increase of 8,801% Compared to Q1 2022 Operating Profit for the First Quarter Increased to $260.7 Million Acquisition of Tingo Foods on February 9, 2023, added $577 Million in revenue to Further Accelerate Growth in Group Revenues and Earnings Management to Host Conference Call Today at 8:00 a.m. Eastern Time MONTVALE, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”) today announced its financial results for the quarter ended March 31, 2023. Following the completion of the acquisition of 100% of Tingo Mobile Limited (“Tingo Mobile”) on November 30, 2022, today’s results are the first to present a full quarter of consolidated financial statements of Tingo and Tingo Mobile. In addition, today’s results include the...